Actionable news
All posts from Actionable news
Actionable news in ZYNE: Zynerba Pharmeceuticals Inc,

Zynerba Pharmaceuticals: Buy This Marijuana Stock Ahead Of Upcoming Phase 1 Results


It's not the best of times in biotech, but companies with solid science and results are still being rewarded.

GW Pharmaceuticals has sparked interest in biotechs with marijuana based treatments.

Zynerba has multiple upcoming catalysts that should result in increased interest by Wall Street.

Prior third party results in CBD based treatments indicate a better than average chance of future success.

ZYNE: A Buy Ahead of Upcoming Phase 1 Data

It's definitely not the best of times to be in biotech if you're judging by the recent performance of the iShares Nasdaq Biotechnology...